1. 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. Issue 7 (2nd October 2018) Authors: Lipplaa, Astrid; Fernandes, Ricardo; Marshall, Andrea; Lorigan, Paul; Dunn, Janet; Myers, Kevin; Barker, Emily; Newton-Bishop, Julia; Middleton, Mark; Corrie, Pippa Journal: British journal of cancer Issue: Volume 119:Issue 7(2018) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma. (9th November 2020) Authors: Weber, Jeffrey; Ascierto, Paolo; Middleton, Mark; Hennicken, Delphine; Zoffoli, Roberto; Pieters, Anne; Amadi, Adenike; Kupas, Katrin; Kotapati, Srividya; Moshyk, Andriy; Schadendorf, Dirk Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in patients with solid tumors. (10th December 2020) Authors: Aroldi, Francesca; Sacco, Joseph; Harrington, Kevin; Olsson-Brown, Anna; Nanclares, Pablo; Menezes, Lavita; Bommareddy, Praveen; Thomas, Suzanne; Kaufman, Howard; Samakoglu, Selda; Coffin, Robert; Middleton, Mark Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts. (9th November 2020) Authors: Middleton, Mark; Aroldi, Francesca; Sacco, Joseph; Milhem, Mohammed; Curti, Brendan; MBioeth, Ari VanderWalde; Baum, Scott; Samson, Adel; Pavlick, Anna; Chesney, Jason; Niu, Jiaxin; Rhodes, Terence; Bowles, Tawnya; Conry, Robert; Olsson-Brown, Anna; Laux, Douglas Earl; Kaufman, Howard; Bommareddy... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An on-call escape room: Escaping the monotony of a didactic induction for doctors. (3rd April 2023) Authors: Lam, Angela; Rogerson, Frances; Emery, Rachel; Middleton, Mark Journal: Medical teacher Issue: Volume 45:Number 4(2023) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-VCAM-1 targeted MRI allows earlier detection of brain metastases in a xenograft melanoma mouse model. (31st January 2018) Authors: Cheng, Vinton; Soto, Manuel Sarmiento; Khrapichev, Alexandr; Perez-Balderas, Francisco; Middleton, Mark; Sibson, Nicola Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 1 Page Start: i13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bony increased-offset reverse shoulder arthroplasty: A meta-analysis of the available evidence. (February 2021) Authors: Dimock, Richard; Fathi Elabd, Mohamed; Imam, Mohamed; Middleton, Mark; Godenèche, Arnaud; Ali Narvani, A Other Names: Zuckerman Joseph D. guest-editor. Journal: Shoulder & elbow Issue: Volume 13:Number 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Burden of cancer trial participation: A qualitative sub-study of the INTERIM feasibility RCT. (March 2023) Authors: Nwolise, Chidiebere; Corrie, Pippa; Fitzpatrick, Ray; Gupta, Avinash; Jenkinson, Crispin; Middleton, Mark; Matin, Rubeta Journal: Chronic illness Issue: Volume 19:Number 1(2023) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study. (November 2022) Authors: Lee, Lennard Y.W.; Ionescu, Maria C.; Starkey, Thomas; Little, Martin; Tilby, Michael; Tripathy, Arvind R.; Mckenzie, Hayley S.; Al-Hajji, Youssra; Appanna, Nathan; Barnard, Matthew; Benny, Liza; Burnett, Alexander; Cattell, Emma L.; Clark, James J.; Khan, Sam; Ghafoor, Qamar; Panneerselvam, Hari... Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). (June 2019) Authors: Lebbe, Celeste; Garbe, Claus; Stratigos, Alexander J.; Harwood, Catherine; Peris, Ketty; Marmol, Veronique del; Malvehy, Josep; Zalaudek, Iris; Hoeller, Christoph; Dummer, Reinhard; Forsea, Ana Maria; Kandolf-Sekulovic, Lidija; Olah, Judith; Arenberger, Petr; Bylaite-Bucinskiene, Matilda; Vieira,... Journal: European journal of cancer Issue: Volume 114(2019) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗